Literature DB >> 10593704

Assuring bioavailability of fixed-dose combinations of anti-tuberculosis medications. A joint statement of the International Union Against Tuberculosis and Lung Diseases and the World Health Organization.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10593704

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  4 in total

Review 1.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Fixed-dose combination drugs for tuberculosis: application in standardised treatment regimens.

Authors:  Bjørn Blomberg; Bernard Fourie
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.

Authors:  Abraham Aseffa; Joseph N Chukwu; Mahnaz Vahedi; Emmanuel N Aguwa; Ahmed Bedru; Tesfamariam Mebrahtu; Oliver C Ezechi; Getnet Yimer; Lawrence K Yamuah; Girmay Medhin; Cathy Connolly; Wasima Rida; Getachew Aderaye; Alimuddin I Zumla; Philip C Onyebujoh
Journal:  PLoS One       Date:  2016-06-20       Impact factor: 3.240

4.  Quality assurance of rifampicin-containing fixed-drug combinations in South Africa: dosing implications.

Authors:  R Court; M T Chirehwa; L Wiesner; B Wright; W Smythe; N Kramer; H McIlleron
Journal:  Int J Tuberc Lung Dis       Date:  2018-05-01       Impact factor: 2.373
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.